Monoclonal antibody 3F12 identifies a cytoplasmic antigen of 49 kDa in human hippocampus and neocortex. The distribution of 3F12 immunoreactive neurons closely matches that of Alzheimer's disease (AD) targeted neurons in these areas. In some hippocampal neurons of AD patients, this antigen colocalizes with ALZ-50, indicating the presence of AD pathology in these neurons. Molecular characterization of the 3F12 cDNA revealed it to be a member of the MAP kinase family, showing 43% amino acid sequence identity to human extracellular related kinase 2 (p42maP"). We have confirmed that p493F12 kinase autophosphorylates both threonine and tyrosine residues, as expected for a MAP kinase. The p49 mRNA is expressed exclusively in the nervous system. In the brain, the distribution of these neurons closely corresponds to 3F12 antigenbearing neurons. The p493F12 gene maps to the human chromosome 21q21 region, a region that may be important in the pathogenesis of AD and Down's syndrome.
Introduction
The mitogen activated protein (MAP) kinases have emerged as key switch kinases that initiate a cascade of serine/ threonine phosphorylation signals (Ray and Sturgill, 1987; Payne et al., 1991) . The evolutionarily conserved family of MAP kinases includes at least three vertebrate kinases: p42 mapk (extracellular related kinase 2 [ERK2]), p44 rnapk (ERK1), and p55 ma~k (ERK3; Bou Iton et al., 1991 ) . The cascade may also be activated in response to a variety of stimuli, such as those from G protein-coupled receptors (Gardner et al., 1993) and intracellular calcium mobilization (Chao et al., 1992) .
Although MAP kinases are expressed ubiquitously in vertebrate tissues, they appear to be enriched in neural tissues. Boulton et al. (1991) have shown that ERK1, ERK2, and ERK3 mRNAs are expressed at highest levels in the nervous system of adult rats, with ERK2 and ERK3 displaying alternative patterns in certain brain regions. The human ERK3 (also known as p63 r"apk) shows high levels of expression in heart and brain (Gonzalez et al., 1992) .
MAP kinases may play a special role in terminally differentiated neurons. ERK1, ERK2, and ERK3 are all expressed in adult neurons, indicating a role for these enzymes other than in cell proliferation. There is also evidence indicating that MAP kinases may be regulated by nerve growth factor (NGF); NGF-dependent stimulation of neurite outgrowth in PC12 cells coincides with a 30-fold increase in MAP kinase activity and translocation of the kinase to the nucleus. Furthermore, MAP kinases may also be involved in the regulation of the NGF-induced G1 arrest of PC12 cells (Rudkin et al., 1989) .
Several experiments suggest an involvement in the regulation of cytoskeletal elements by MAP kinases. ERK1 and ERK2 are associated with the microtubule organizing centers during meiotic maturation of mouse oocytes (Verlhac et al., 1993) . Disruption of microtubules by colchicine in rat fibroblasts leads to activation of a serine/threonine kinase similar in chromatographic properties to MAP kinases (Shinohara-Gotoh et al., 1991) .
Perturbations in the regulation of MAP kinases may be involved in pathological processes of human brain. In AIzheimer's disease (AD), several neuronal cytoskeletal proteins have been shown to be abnormally phosphorylated (Arai et al., 1990) . One of these proteins, microtubuleassociated protein tau, is abundant in axons, where it stabilizes microtubules (Drechsel et al., 1992) . Abnormally phosphorylated tau is the primary constituent of the neurofibrillary tangles (NFT), a pathological hallmark of AD (Goedert et al., 1989) . MAP kinase is able to hyperphosphorylate tau in vitro, causing it to acquire abnormal biochemical properties similar to those found in AD NFTs (Lu et al., 1993) . The ERK2 protein is immunocytochemically localized to NFTs and dystrophic neurites associated with senile plaques (Trojanowski et al., 1993) . In vitro, ERK2 is able to phosphorylate 14-16 proline-directe d serine or threonine residues on tau, whereas normal tau in adult brain has 2-3 phosphorylated sites (Drewes et al., 1992; Goedert et al., 1992) .
Although some kinase isozymes display regional and cell type specificity in the brain, no neuronal subset specificity for any of the known serine/threonine kinases, including MAP kinases, has yet been reported. We previously described neuronal su bset-specific expressiOn of a cytoplasmic protein immunoreactive with MAb 3F12 in a subpopulation of pyramidal neurons in the human hippocampus and neocortex (Miller and Benzer, 1983; Miller et al., 1987; Hinton et al., 1988) . Immunoblots of homogenates of human hippocampus detect four immunoreactive bands of 60, 49, 45, and 42 kDa. We also reported the loss of MAb 3F12 immunoreactivity in neurons of AD patients early in the course of the disease. This pattern of loss corresponds, topographically, to the pattern of neuronal degeneration (Miller et al., 1987; Hinton et al., 1988) .
Here, we report the cloning and sequencing of the p493F12 cDNA and the identification and partial characterization of its protein product that exhibits significant sequence similarity to members of the MAP kinase family. This kinase is present in a subpopulation of neurons and can colocalize with the ALZ-50 antigen in AD hippocampal sections. Expression of the gene provides a marker for the subset of neurons targeted in AD. 
Results

Immunocytochernical Characterization of the Antigen
MAb 3F12 stained a subpopulation of pyramidal neurons in the CA4, CA1, and subiculum regions of the hippocampus and layers 3 and 5 of the neocortex in neurologically normal human brain. Staining was localized to somas and the proximal portions of apical dendrites (Figures 1A and 1B) . Some axons were labeled in the white matter of the cerebrum, spinal cord, and the brainstem ( Figure 1C ).
Hippocampal sections from AD patients were double stained with MAbs 3F12 and ALZ-50. MAb ALZ-50 identifies abnormally phosphorylated tau proteins and is a marker for early neurofibrillary degeneration in AD (WoIozin et al., 1986) . The 3F12 and AI 7-50 antigens, labeled with fluorescein isothiocyanate (FITC) and Texas Red, respectively, colocalized in some pyramidal neurons in the CA4, CA1, and subiculum regions. These results confirm that antigen 3F12 is expressed in neurons vulnerable in AD. The 3F12 antigen present in the somal cytoplasm and the proximal apical dendrites was displaced by punctate deposits immunoreactive with MAb ALZ-50 (Figures 2A  and 2B ). In some neurons, ALZ-50 staining was more extensive and occupied the entire neuronal soma, with little to no remaining 3F12 reactivity.
Molecular Cloning of the 3F12 cDNA
We screened a human hippocampal Xgt11 cDNA expression library with MAb 3F12. Among 300,000 plaques, 3 positive clones were isolated with insert sizes of 450,420, and 351 bp. Each clone was labeled with 33p and hybridized in situ to human hippocampal sections. Only one clone (HH3,351 bp) hybridized to a subpopulation of pyramidal neurons in a distribution very similar to that of MAb 3F12 immunoreactivity ( Figures 3A-3F ). DNA sequence analysis of this clone and comparison with sequences in GenBank revealed it to be novel.
To obtain a full length cDNA clone, the 32P-labeled 351 bp clone was used to screen a ZZAPII, oligo(dT)-primed human hippocampal library. After screening 150,000 plaques, a 2.4 kb cDNA clone with an exact nucleotide sequence match with clone HH3 was isolated. The low abundance indicated that it was a rare mRNA species, in agreement with the low quantities of MAb 3F12 immunoreactive proteins in hippocampal tissue homogenates. By primer extension, using an antisense primer hybridizing near the 5' end of the 2.4 kb cDNA, it was determined that this cDNA clone lacked 260 bases from the 5' untranslated region (UTR; data not shown). Nonetheless, it contained the complete amino acid coding sequence of the p493F~2 kinase. The 2.4 kb cDNA clone labeled with 33p also hybridized in situ to the same distribution of neurons as clone HH3.
Sequence Analysis of the cDNA
The nucleotide sequence of the clone revealed it to be 2411 bp in length ( Figure 4A) . A continous open reading frame encoding 422 amino acids began at position 223. Three additional ATGs in the 5' UTR were all followed by in-frame stop codons. There was also a 3' UTR of 918 bp beginning at position 1492. A 34 bp poly(A) tail was present beginning at position 2372, with a possible polyadenylation signal at position 2351. The Kyte-Doolittle hydropathy analysis of the predicted amino acid sequence did not reveal any extended hydrophobic regions that would suggest a membrane-spanning domain. A schematic representation of the p493r12 kinase domains indicates the presence of the ATP-binding domain, two TXY phosphorylation sites separated by two valine residues and the serine/threonine catalytic sequence (Hanks et al., 1988) (Figure 4B ).
Nucleotide searches of the GenEMBL database using the blastn program revealed 75% identity with clone HFBCL46 (GenBank accession number M85653) beginning at position 14 and ending at position 373 of the 3F12 cDNA sequence. Swiss-Pro protein database searches with 3F12 amino acid sequence did not match any known proteins; the 3F12 deduced protein sequence is novel. However, significant amino acid sequence homology to MAP serine/threonine kinases was observed. There was a 42% sequence identity between the predicted amino acid sequence of 3F12 cDNA and that of the human ERK2 (p42maPk). A gap alignment of the kinase with human ERK1, ERK2, ERK3, and Saccharomyces cerevisiae LYT2 and FUS3 is shown in Figure 5A . The percent amino acid identities among these kinases are shown in Figure 5B .
Distribution of the mRNA
Northern blots of human hippocampus, primary motor cortex (Brodmann's area 4), frontal association cortex (area 10), primary visual cortex (area 17), cerebellum, spinal cord, and cerebral white matter were probed with a 32p. labeled 1.0 kb cDNA fragment, corresponding to the first 1000 bases of the 2.4 kb cDNA clone ( Figure 6A) . A 2.7 kb mRNA species was identified in the hippocampus and areas 4, 10, 17, the cerebellum, with a weak signal in the spinal cord. White matter, which lacks neuronal cell bodies, did not show expression of the mRNA, in keeping with the localization of the antigen to neurons. Furthermore, analysis of mRNA from other brain regions revealed expression of the 2.7 kb mRNA in striatum and brain stem ( Figure 6B ). The expression of the 3F12 mRNA species was also examined in other tissues. In northern blots of poly(A) + mRNA from heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, and testis, only kidney ( Figure  6C ) and testis ( Figure 6B ) showed very weak hybridization to a 2.7 kb species. Other tissues showed no detectable expression ( Figure 6C ).
Autophosphorylation of 3F12 MAP Kinase
To test for phosphorylation activity of the p493F12 kinase, a plasmid (pTrcHis-3F12) was constructed in which the kinase was expressed as a 49 kDa fusion protein in Escherichia coli after induction by isopropyl ~-D-thiogalactopyranoside (IPTG; Figure 7A ). The fusion protein was purified to >95% homogeneity for further analysis.
Incubation of the recombinant p493F~2 kinase with buffer and [y-32P]ATP resulted in phosphorylation of the purified protein ( Figure 7B ). Heat inactivation of the pure protein before autophosphorylation prevented incorporation of Figure 3 . In Situ Localization of the p493F12 Kinase mRNA in Neurologically Normal Hippocampus Hippocampal sections were probed with ~P-labeled antisense (A and D) and sense (B and E) p493F12 cRNA probes generated from the full-length 2.4 kb cDNA. A subpopulation of pyramidal neurons in the CA4, CA1, and subiculum regions of the hippocampus were labeled. ~,-APP ~P-labeled antisense cRNA probe was used to determine the integrity of mRNA on tissue sections (C). This probe hybridized to all neurons. Sections were viewed under dark field and light field, respectively. In dark field low magnification (A), silver grains are abundant over neurons in the CA1 region. A concentration of grains over CA1 pyramidal neurons counterstained with Giemsa are seen in light field at higher magnification (D). All slides were exposed to silver emulsion for 6 days at 4°C except I3-APP, which was exposed for 3 clays (C). A schematic of the human hippocampus delineates regions where neurons immunoreactive with MAb 3F12 (closed triangles) and neurons expressing p493F'2 kinase mRNA (closed circles) are located (F). An almost identical distribution of positive neurons is seen in both assays. Open triangles denote nonreactive neurons by immunocytochemistry or in situ hybridization. Note that in (B) and (E), a few grains are present over neurons, owing to background from long exposure times. Bars, 0.1 mm (A, B, and C); 10 ilm (D and E). 32p, thus discounting the possibility that tyrosine phosphorylation was due to a nonenzymatic reaction (Seger et al., 1991) . Phosphoamino acid analysis of the labeled protein revealed that phosphate was incorporated onto both tyrosine and threonine residues ( Figure 7C ). The kinase was also autophosphorylated with cold ATP. It showed strong immunoreactivity with antibodies to phosphotyrosine on Western blots. Immunoreactivity could be blocked by the addition of excess phosphotyrosine ( Figure 7D ).
Identification of the Kinase on Immunoblots
Polyclonal antisera generated against the p49 bacterial recombinant protein (anti-p49)identified three immunoreactive proteins of 49, 45, and 35 kDa in Triton X-100 soluble supernatants of human hippocampal homogenates ( Figure 8B , lane 1). In a pure preparation of p49 bacterial fusion protein, anti-p49 immunoreactive bands of the same relative mobilities were identified, the band at 49 kDa being the dominant form ( Figure 8B , lane 2). MAb 3F12 identified immunoreactive bands at 68, 49, 45, 42 (doublet) , and 35 kDa ( Figure 8A , lane 1). The immunoreactive bands of 49, 45, and 35 kDa comigrated with those identified by anti-p49. As expected, MAb 3F12 also reacted with the p49 kinase fusion protein ( Figure 8A , lane 2). The no-primary-antibody control indicated the presence of a 70 kDa band immunoreactive with the biotinylated secondary antibody ( Figure 8C , lane 1). However, this band was clearly distinct from the MAb 3F12 immunoreactive band at 68 kDa. To confirm that anti-p49 and MAb 3F12 recognize the same protein, we purified p49 from hippocampal homogenates by immunoaffinity chromatography using anti-p49. The immunopurified protein was probed on Western blots with MAb 3F12. Both anti-p49 ( Figure 8D , lane 1) and MAb 3F12 ( Figure 8D , lane 2) recognized the same protein at 49 kDa.
Chromosomal Mapping of the Gene
To determine the chromosomal location of the p493F12 kinase gene, 32P-labeled 2.4 kb cDNA was used to probe Southern blots of hamster somatic hybrid lines. These cell lines harbor at least one human chromosome in addition to the hamster genome. Two unique bands at 5.5 and 2.3 kb (the most intense bands on the blot) were identified in DNA from the cell line containing human chromosome 21 (data not shown). For finer mapping, a 12.5 kb human genomic clone was isolated from a XFixll human genomic library by screening with 32P-labeled 2.4 kb cDNA probe. This clone was then biotin labeled by nick translation and 
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Eue~kl I hybridized, along with a chromosome 21 specific cosmid probe, to human metaphase spreads by fluorescence in situ hybridization (FISH). Four fluorescent dots corresponding to areas of probe hybridization were observed on the q arm of chromosome 21 (Figure 9 ). The two most distal dots hybridized to the telomeric sequences of chromosome 21 as expected, since the cosmid is specific for these sequences. Two other fluorescent dots were observed at the approximate region of 21q21 ( Figure 9 , inset). These were due to the p493F'2 probe, since spreads hybridized with the 21 specific cosmid alone showed only the two telomeric dots. The approximate location of the p493F12 gene was determined by the measurement of the relative distance from the most proximal portion of the (C) mRNAs (2 p.g) from various human tissues were probed with 32P-labeled 3F12 cDNA and exposed to X-ray film for 6 days. Lane 1, heart; lane 2, brain; lane 3, placenta; lane 4, lung; lane 5, liver; lane 6, skeletal muscle; lane 7, kidney; lane 8, pancreas. Note that other than in brain, there is hybridization close to threshold only in the kidney. Integrity of the mRNA was established by probing the blots with human ~-actin (lower panels). short arm to the area of probe hybridization and subsequent comparison to a map of human chromosome 21.
Discussion
We have identified the 3F12 neuronal-specific antigen as a novel member of the MAP kinase family, partially confirmed its function, and determined its expression in normal human brain and in various somatic tissues. We have also shown that in brain tissues from patients with AD, MAb 3F12 antigen colocalizes with MAb ALZ-50 in neurons with neurofibrillary pathology. In the human hippocampus, the kinase is distributed in subsets of neurons vulnerable in AD. Furthermore, we have mapped the location of the corresponding gene to the region of 21q21. In contrast to most MAP kinases described so far, which . Chromosomal Localization of the p493F~2 Kinase Gene by FISH The 12.5 kb p493 F12 human genomic clone and the chromosome 21-specific cosmid probe were biotin labeled by nick translation and hybridized to human metaphase spreads. The probes were detected using streptavidin-FITC on chromosomes that were counterstained with propidium iodide. Low magnification shows specific hybridization of the p493F12 probe (two yellow-green dots) to the long arm of human chromosome 21 (arrow in the inset). The two distal dots are due to hybridization of the human chromosome 21-specific cosmid probe to the telomeric region (arrowhead in the inset).
(Inset) High magnification shows the region of hybridization to be approximately 21q21 (arrow in the inset) as determined by measurement of the distance from the most distal portion of the short arm to the region of hybridization of the p49 probe. Bar, 10 p.m. are ubiquitously expressed, p493F~2 kinase expression is restricted to a subset of projection neurons in the nervous system. Analysis of the kinase mRNA by Northern blots and in situ hybridization in various human brain sites revealed expression in a subset of pyramidal neurons in the CA1 and subiculum regions of the hippocampus and in layers 3 and 5 of Brodmann's areas 4, 10, and 17 of the neocortex. Additionally, p493F~2 mRNA was detected in subcortical nuclei and brainstem. In nonneural tissues, only the testis and kidney showed markedly lower levels of expression. The lack of any detectable signal in the white matter poly(A) ÷ mRNA and the weak signal in the spinal cord is in agreement with the regional and neuronal specificity of the 3F12 antigen. To date, the sequence of the p493F~2 kinase is novel. However, a previously described cDNA (clone HFBCL46 [EST02170] )from the dBEST library of sequences showed 75% identity with the 3F12 nucleotide sequence. The relatively short clone of 359 bp contains many alignment gaps and nucleotide mismatches. Therefore, it is difficult to determine whether the p493F~2 kinase and HFBCL46 are the same clone.
The kinases most closely related to p493F12 are rat ERK1 and human ERK2, which show 41% and 43% amino acid sequence identity, respectively. Both of these kinases have been classified as members of the MAP kinase family and contain a tripeptide (TXY) in the kinase catalytic region. Interestingly, the deduced amino acid sequence of p49 contains two TXY phosphorylation sites separated by two valine residues. This second site may be an additional regulatory element, providing for tighter control of the action of this kinase. Phosphopeptide mapping and sitedirected mutagenesis studies have revealed that phosphorylation of threonine and tyrosine residues in this tripeptide are required for maximal kinase activity; even conservative substitution of tyrosine residues reduces activity of the enzyme (Seger et al., 1991) . Although Xenopus MAP kinase possesses weak autophosphorylation activity in vitro, deletion of its ATP-binding domain, which abolishes activity of the kinase, does not seem to interfere with phosphorylation of the tripeptide in vivo (Nakielny et al., 1992) . To ascertain the functional capacity of p493F12 kinase, we performed autophosphorylation assays with a bacterially produced fusion protein. This kinase possesses weak autophosphorylation activity; the activity is real; it is abolished by exposure to temperatures of 55°C or higher. Incubations of 1 hr or more were required to generate a strong signal. Thus, p493F12 kinase resembles other MAP kin ases in that it does not readily autophosphorylate, suggesting that autophosphorylation may not be important for its activation in vivo.
Our studies confirmed that the 49 kDa protein identified by both MAb 3F12 and anti-p49 is the neuronal protein. MAb 3F12 identified two additional proteins of 68 and 42 kDa in hippocampal homogenates. Since these bands are not identified by anti-p49, it is likely that they constitute other related kinases or shared epitopes. The 45 and 35 kDa bands, identified by both MAb 3F12 and anti-p49 in hippocampal homogenates, may be postmortem or preparative degradation products or differentially phosphorylated forms of p493F12 kinase. Anti-p49 also identified bands with the same relative mobilities in the lane containing the purified fusion protein. Moreover, MAb 3F12 identified immunoaffinity purified p49 from hippocampal homogenates. Anti-p49 was not immunoreactive on tissue sections of human hippocampal and frontal cortex. One possible explanation is the masking of epitopes in the native conformation of the kinase in tissue.
ERK1 and ERK2 are expressed in most neurons and reactive astrocytes in the human brain (Hyman, et al., 1994) . It is likely that these kinases are also expressed in the subset of neurons expressing p493F12 kinase. ERK1 and ERK2 are regulated by activator kinases such as B-raf and MEK, which are not only expressed in dividing cells, but also in terminally differentiated neurons (Kyriakis et al., 1992) . NGF stimulates the action of MAP kinases and the raf-1 protein kinase in PC12 cells (Ohmichi et al., 1992) . It would be intriguing to determine whether raf-1 is also capable of activating p493F~2 kinase. If so, a mechanism for selective activation of MAP kinases including p49 may exist, allowing targeting of these enzymes to various substrates.
MAP kinases have been implicated in the phosphorylation and activation of transcription factors such as c-myc (Seth et al., 1991) . The mechanism of activation of these factors remains controversial; however, activation of MAP kinase in cells expressing these proteins results in increased expression of genes that contain promoterbinding sites for these factors. If p493F12 plays a role in activation of some of these factors, its subset specificity may provide an additional level of regulation, resulting in increased or decreased expression of other genes within the MAb 3F12 immunoreactive subset.
MAP kinases may also be involved in aberrant regulation of the neuronal cytoskeleton; they are capable of abnormally phosphorylating microtubule-associated protein tau at 14-16 proline-directed serine/threonine residues (Drewes et al., 1992) . These events may be a precursor for the formation of the NFTs in AD. Localization of the p493F12 kinase to axons and neuronal cell bodies of projection neurons (primarily affected in AD) may provide the opportunity for interaction with tau or other cytoskeletal proteins.
To date, none of the described MAP kinases are restricted in expression to areas containing tangle-bearing neurons. The role of MAP kinases in AD pathology, including the generation of paired helical filaments, has been examined in several laboratories. In biochemical studies, Xenopus MAP kinase converts normally phosphorylated microtubule-associated protein tau into an abnormally phosphorylated form recognizable with antibodies specific for NFTs (Drewes et al., 1992; Goedert et al., 1992; Lu et al., 1993) . MAP kinases that recognize proline-directed phosphorylation sites (e.g., ser-pro or thr-pro) seem to be better able to catalyze the transformation of normal tau into an abnormally phosphorylated form than are other kinases, such as Ca2+/calmodulin-dependent kinase (Ca/ CaM kinase) or protein kinase C I.
The approximate location of the p493F12 kinase gene to the region of 21q21 may be significant in the pathogenesis of Alzheimers disease and Down's syndrome. The I~-amyIoid precursor protein (13-APP) gene has been mapped to the region of 21 ql 1.2-q21 and the putative Down's syndrome locus to 21q22.3 (Korenberg et al., 1990) . Almost all Down's syndrome patients past the age of 35 develop AD-like pathology (NFT and senile plaques) in the brain. One putative locus segregating with the early onset of familial AD phenotype in some pedigrees has also been identified in the region 21q11.2-21q22.2 (St George- Hyslop et al., 1987) . The 13-APP also undergoes phosphorylation on its C-terminal cytoplasmic domain by protein kinase C and Ca/CaMII kinase, leading to its detachment from cytoskeletal components and possible increased vulnerability to proteolysis (Gandy et al., 1988; Refolo et al., 1991) . Speculatively, a gene duplication event involving the p493F12 kinase could lead to its overexpression and abnormal phosphorylation in the brains of Down's syndrome patients. In the case of the familial AD patients, possible mutational events or overexpression of the p493F12 kinase could also result in aberrant function.
We have described the cloning and partial characterization of a novel neuron-specific MAP kinase. The mRNA is expressed in a subset of neurons in the human hippocampus and neocortex. The protein colocalizes with ALZ-50 in AD-vulnerable neurons in the hippocampus, and the gene is located on 21q21, a region that is implicated in AD and Down's syndrome pathogenesis. The kinase may function by phosphorylating neuronal cytoskeletal elements or transcription factors in response to specific stimuli.
Experimental Procedures
Immunohistochemistry
Human tissues were obtained from Alzheimer's Disease Research Consortium of Los Angeles and Orange Counties. Tissue blocks from human hippocampus, neocortex, cerebellum, spinal cord, and white matter from patients ages 35-56 were snap-frozen at autopsy and stored at -90°C. The average postmortem interval was 8 hr for normal and 4 hr for AD patients. Cryostat sections (8-10 p.m) were incubated sequentially with the primary antibody, biotinylated goat anti-mouse IgM, avidin-biotin complex (Vector Labs), and diaminobenzidine. The sections were then viewed with an EDGE high resolution microscope (EDGE Instruments).
For double labeling experiments, sections were incubated with the first primary antibody, followed by FITC-conjugated goat anti-mouse IgM (Cappell Labs). Following two washes in 1 x phosphate-buffered solution (PBS), they were incubated sequentially with the second primary antibody, biotinylated goat anti-mouse IgM and Texas Red-conjugated streptavidin (Vector Labs). Following washes, the sections were mounted in vectashield (Vector Labs) and viewed under epifluorescence using a double bypass filter for FITC and Texas Red. MAb 3F12, an IgM, was the generous gift of Dr. Seymour Benzer; MAb ALZ-50, also an IgM, was donated by Dr. Peter Davies.
Immunoblots
Tissues were homogenized 1:5 (g/ml buffer) using a Dounce teflon homogenizer in 0.1 M phosphate buffer (pH 7.4), 0.1 M NaCI containing 1% Triton X-100, and 2 p.m phenyl methyl sulfonyl fluoride (PMSF) and were centrifuged at 100,000 x g for 30 min. The supernatant was then diluted 1:1 with 2x SDS-sample buffer, boiled for 2 min, and fractionated on 10% SDS-polyacrylamide gel. The proteins were electroblotted onto nitrocellulose filters, blocked in 4% dry milk in 0.1% Triton X-100-PBS (-IPBS), and incubated overnight with antibody diluted in TPBS at 4°C. Following washes, blots were sequentially incubated with biotinylated secondary antibody, streptavidin-biotinhorseradish peroxidasa (HRP) complex and aminoethylcarbazol. For immunoaffinity chromatography, anti-p49 (IgG) was purified on Avid-AI beads (UniSyn Technologies) and bound to Affigel-10 agarose according to the protocol of the manufacturer (BioRad Laboratories). The supernatant from human hippocampal homogenates prepared as above was incubated with beads overnight at 4°C followed by washes in homogenization buffer. The proteins were then eluted from the beads by boiling in 2x SDS sample buffer and analyzed on Western blots.
Construction of Human Hippocampus cDNA Library
RNA from adult human hippocampus was prepared by the guanidine isothiocyanate acid-phenol method (Chomczynski and Sacchi, 1987) . Poly(A) ÷ mRNA was isolated by two rounds of oligo(dT) cellulose chromatography. The construction of an oligo(dT)-primed cDNA library followed the method of Gubler and Hofmann (Sambrook et al., 1989) , with some modifications. The cDNA was ligated into dephosphorylated, EcoR1 cut ~.ZAPII arms and packaged in vitro.
cDNA Cloning and DNA Sequencing
MAb 3F12 was used for immunoscreening a random-primed human hippocampal Xgtl 1 expression library (CIontech). Positive clones were plaque purified, and inserts were excised by EcoRI restriction digestion. The insert from clone HH3 was then labeled with ~P by random hexamer priming and used to screen the XZAPII human hippocampal cDNA library under high stringency conditions. Positive clones were plaque purified. To obtain plasmids from isolated phage clones, phagemid rescues were performed using the excision protocol. The DNA sequences of the clones were determined using the sequenase system (United States Biochemical). Both strands were sequenced in their entirety.
The DNA sequence and its deduced amino acid sequence were compared with contents of the GenBank DNA and the Swiss-Pro protein databases using the FASTA and the TFASTA and BLAST programs, respectively. The comparisons were performed using the sequence analysis programs from the University of Wisconsin Genetics Computer Group for the VAX/VMS system (Devereux et al., 1984) .
In Situ Hybridization
Human hippocampal sections were cut and fixed in 40/o paraformaldehyde, washed in 1 x PBS for 15 min at room temperature, and exposed to acetic anhydride (0. 25O/o [v/v] in 0.1 M triethanolamine [pH 8]). The sections were washed twice with 2x SSC, dehydrated through increasing concentrations of ethanol, and air dried. The sections were overlaid with 30-50 ng of p49 z~12 kinase ~P-labeled cRNA probe in 30 Id of hybridization buffer containing 5 x SSC, 5 x Denhart's solution, 50% formamide, 100 pg/ml of heat denatured salmon sperm DNA, 20 I~g/ml of yeast tRNA (Sigma), and 10% Dextran sulfate. Sections were coverslipped and placed in a humidified incubator overnight at 37°C. Coverslips were removed, and the slides were washed in 0.2 x SSC at 50°C and 60°C for 1 hr each. The sections were dehydrated in ethanol, coated with Kodak NTB-2 emulsion, and exposed in the dark at 4°C. After 10 days, the slides were developed and counterstained with Giemsa.
Northern Blot Analysis
Total cellular RNA was prepared from postmortem human tissue by the guanidinium isothiocyanate acid phenol method (Chomczynski and Sacchi, 1987) . Poly(A) + mRNA (5 p.g) was fractionated on glyoxal/dimethyl sulfoxide gels and transferred to Nytran membranes (Schleicher and Schuell). RNA was UV cross-linked, and the membrane was air dried. Filters were prehybridized in 6x SSPE, 10x Denhart's, 50% formamide, 1% SDS, and 200 p.g/ml of denatured salmon sperm DNA. 32P-labeled p493F12 cDNA (10-50 ng; first 1000 bp) probe was added to the prehybridization mixture, followed by overnight incubation at 37°C. Washes were carried out in 0.1 x SSC at 65°C. Filters were placed on enhancing screens (Cronex, Dupont) and exposed to X-ray film at -70°C for 3-7 days for p493F~2 and 12 hr for ~-actin.
Expression and Purification of 3F12 MAP Kinase
The 3F12 MAP kinase cDNA was cloned into the PstI-Kpnl sites of the pTrcHis A expression vector (Invitrogen). The construct was transformed into E. coil, and the fusion protein was expressed and purified on a Ni-NTA column as per the instructions of the manufacturer (Qiagen). The resultant fusion protein contained a 6x histidine tag, an enterokinase cleavage site, and the 3F12 MAP kinase from amino acid 8-422.
Kinase Assays
Autophosphorylation was performed by incubating the 3F12 MAP kinase fusion protein in kinase buffer (25 mM HEPES, 10 mM MgCI2, 2 mM MnCI2, 1 mM dithiothreitol [pH 7.5], and 100 ~M [y-32P]ATP) at 30°C for 1 hr (Seger et al., 1991) . The reaction was terminated by adding SDS electrophoresis sample buffer and heating to 100°C for 3 min. The phosphorylated fusion protein was separated by electrophoresis on a 9% SDS-polyacrylamide gel, blotted onto a polyvinylidine difluoride membrane, and detected by autoradiography on Kodak X-OMAT AR film.
3F12 MAP kinase fusion protein was treated as described above, except unlabeled ATP was substituted for labeled ATP. The membrane was blocked with 5% bovine serum albumin for 1 hr, incubated with a 1:1000 dilution of anti-phosphotyrosine (Sigma), and washed with PBS/0.1% Tween 20. The membrane was then incubated with horseradish peroxidase-conjugated anti-mouse IgG, washed, and visualized with 1-chloro-naphthol. Phosphoamino acid analysis was done as previously decribed (Crews et al., 1991) .
Genomic Cloning and FISH
A human ;~Fixll (Stratagene) placenta genomic library was screened with 32P-labeled 2.4 kb cDNA probe. A clone with an insert size of approximately 12.5 kb with multiple internal EcoRI sites was isolated. The EcoRI fragments were gel purified on low melt agarose and labeled with biotin by nick translation.
For FISH, slides with metaphase spreads were denatured in 2 x SSC, 70% formamide at 70°C for 2 min and dehyrated in 70% and 950/0 ethanol for 2 rain each (Trask, 1991) . The slides were then hybridized overnight at 37°C in buffer containing 2 x SSC, 50% formamide, 200 I~g/ml of sheared salmon sperm DNA, 200 ng of biotin-labeled 3F12 genomic DNA, and 100 ng of a biotinylated cosmid probe specific for human chromosome 21 telomeric sequences (Oncor). After hybridization, slides were washed at 72°C in 2 x SSC for 5 rain, equilibrated in 1 x PBS, and incubated with streptavidin-FITC (Zymed) for 1 hr at room temperature. Following washes in 1 x PBS, slides were mounted in 50 p.I of antifade solution containing 25 mg/ml of triethylenediamine, 50% glycerol, and 200 ng/ml of propidium iodide in 1 x PBS. The slides were viewed under fluorescence and photographed using the Oncor FISH image analysis system. The location of the p493F12 gene was determined by the measurement of the distance from the most proximal portion of the short arm of chromosome 21 to the location of the hybridized probe. The relative location of the hybridized probe was then determined on a map of human chromosome 21 from human gene map 10.
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